SONG PAUL Y. (Chief Executive Officer) purchased 0.1% of their position (243.65 shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $700.60 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/28/2023ACC: 0001209191-23-056768
DirectorOfficer· Chief Executive Officer
Since Sep 2023
+243.65
Net shares
Net buyer
$700.60
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
243.65 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+103.25
Price / share
$2.91
Trade value
$300.46
% of position
0.1%
11/27/2023
170.46K→170.56K
Common Stock
Direct
Shares
+140.40
Price / share
$2.85
Trade value
$400.14
% of position
0.1%
11/27/2023
170.56K→170.70K
Total
Net shares
+243.65
Net value
$700.60
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/27/2023 | P · Purchase | +103.25 | $2.91 | $300.46 | 0.1% | 170.46K | 170.56K |
| Common Stock Direct | 11/27/2023 | P · Purchase | +140.40 | $2.85 | $400.14 | 0.1% | 170.56K | 170.70K |
| Total | +243.65 | $700.60 | ||||||
Derivative Transactions0
No derivative transactions reported